Ambrisentan: prices and alternatives
Ambrisentan is indicated for the treatment of pulmonary arterial hypertension (PAH, WHO Group 1) in adults to improve exercise capacity and delay clinical worsening. It is primarily studied in patients with WHO Functional Class II–III symptoms, including idiopathic, heritable, and connective tissue disease-associated…
3 products with this active ingredient from 2 manufacturers. Official prices from 462 to 1809 EGP.
Every box with this active ingredient, cheapest first.
Informational only — may be inaccurate or incomplete. Don't rely on it medically; verify with a pharmacist.
